BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 16708399)

  • 21. Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine.
    Kao JY; Zhang M; Chen CM; Pierzchala A; Chen JJ
    Immunol Lett; 2006 May; 105(1):16-25. PubMed ID: 16388858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway.
    Delcayre A; Shu H; Le Pecq JB
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):537-47. PubMed ID: 16001959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination with immature dendritic cells combined with CD40mAb induces protective immunity against B lymphoma in hu-SCID mice.
    Ge Y; Xi H; Zhang XG
    Biomed Pharmacother; 2010 Sep; 64(7):487-92. PubMed ID: 20382498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of vaccination with the lysate of heat-shocked tumor cells on nitric oxide production in BALB/c mice with fibrosarcoma tumor.
    Hashemi SM; Hassan ZM; Soudi S; Shahabi S
    Cell Biol Int; 2008 Jul; 32(7):835-40. PubMed ID: 18455932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of a tumour-specific CTL response by exosomes isolated from heat-treated malignant ascites of gastric cancer patients.
    Zhong H; Yang Y; Ma S; Xiu F; Cai Z; Zhao H; Du L
    Int J Hyperthermia; 2011; 27(6):604-11. PubMed ID: 21846196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70.
    Xie Y; Bai O; Zhang H; Yuan J; Zong S; Chibbar R; Slattery K; Qureshi M; Wei Y; Deng Y; Xiang J
    J Cell Mol Med; 2010 Nov; 14(11):2655-66. PubMed ID: 19627400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.
    Balkow S; Loser K; Krummen M; Higuchi T; Rothoeft T; Apelt J; Tuettenberg A; Weishaupt C; Beissert S; Grabbe S
    Exp Dermatol; 2009 Jan; 18(1):78-87. PubMed ID: 19054060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma.
    Briones J; Timmerman J; Levy R
    Cancer Res; 2002 Jun; 62(11):3195-9. PubMed ID: 12036933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.
    Liu B; Ye D; Song X; Zhao X; Yi L; Song J; Zhang Z; Zhao Q
    Vaccine; 2008 Mar; 26(10):1387-96. PubMed ID: 18272260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells.
    Song W; Levy R
    Cancer Res; 2005 Jul; 65(13):5958-64. PubMed ID: 15994975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer.
    Kim HS; Choo YS; Koo T; Bang S; Oh TY; Wen J; Song SY
    Immunol Lett; 2006 Mar; 103(2):142-8. PubMed ID: 16313973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis.
    Chan T; Chen Z; Hao S; Xu S; Yuan J; Saxena A; Qureshi M; Zheng C; Xiang J
    Cancer Gene Ther; 2007 Apr; 14(4):409-20. PubMed ID: 17235354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
    Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A combination of exosomes carrying TSA derived from HLA-A2-positive human white buffy coat and polyI:C for use as a subcellular antitumor vaccination.
    Ren WN; Chang CK; Fan HH; Guo F; Ren YN; Yang J; Guo J; Li X
    J Immunoassay Immunochem; 2011; 32(3):207-18. PubMed ID: 21574092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.
    Bohlen H; Thielemanns K; Tesch H; Engert A; Wolf HJ; van Camp B; Urbain J; Diehl V
    Cytokines Mol Ther; 1996 Dec; 2(4):231-8. PubMed ID: 9384709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer immunotherapy using dendritic cell-derived exosomes.
    Amigorena S
    Medicina (B Aires); 2000; 60 Suppl 2():51-4. PubMed ID: 11188932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
    Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.